2025-01-13T08:12:59-05:00 2024-03-31 BDO USA 200 PARK AVENUE 38TH FLOOR NEW YORK NY 10166 990 2023-04-01 131673104 NATIONAL KIDNEY FOUNDATION INC % PETROS GREGORIOU NATI 2128892210 30 EAST 33RD STREET NEW YORK NY 10016 KEVIN LONGINO CEO 2128892210 2025-01-09 true true Paul Hammerschmidt P01384178 2128858000 2023 2024-10-15 13:58:12Z KEVIN LONGINO 30 EAST 33RD STREET NEW YORK NY 10016 51084570 false 2041 X WWW.KIDNEY.ORG X 1950 NY PREVENT KIDNEY DISEASES, IMPROVE THE HEALTH & WELL-BEING OF INDIV. & FAMILIES AFFECTED BY THESE DISEASES & INCREASE THE AVAILABILITY OF ALL ORGANS FOR TRANSPLANTATION. 24 23 271 20000 0 0 22387636 20413151 16965887 20961589 1867211 2101833 4544583 3209280 45765317 46685853 1142712 1108930 0 0 24698436 27053603 0 0 3351880 20719309 21885239 46560457 50047772 -795140 -3361919 59928791 52473755 28721823 23053949 31206968 29419806 X THE NATIONAL KIDNEY FOUNDATION IS REVOLUTIONIZING THE FIGHT TO SAVE LIVES BY ELIMINATING PREVENTABLE KIDNEY DISEASE, ACCELERATING INNOVATION FOR THE DIGNITY OF THE PATIENT EXPERIENCE, AND DISMANTLING STRUCTURAL INEQUITIES IN KIDNEY CARE, DIALYSIS, AND TRANSPLANTATION. false false 17088426 0 15027622 PROFESSIONAL EDUCATION (SEE SCHEDULE O) 10030955 0 1691209 COMMUNITY SERVICES AND ASSISTANCE TO AFFILIATES (SEE SCHEDULE O) 5980643 432441 2717727 PATIENT SERVICES (SEE SCHEDULE O) 9737430 676489 1529039 42837454 true true false true false false false false false true true false false true true true true false false false false false false false true false false true true true false false false false false false false false true false false false false false false false false true 280 0 true 271 true true true false false false false true true false false false true false false false X 24 23 false false false false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X PETROS GREGORIOU 2128892210 30 EAST 33RD STREET NEW YORK NY 10016 X KEVIN LONGINO CHIEF EXECUTIVE OFFICE 35.0 0.0 X X 484793 0 37845 KERRY K WILLIS CHIEF SCIENTIFIC OFFICER 35.0 0.0 X 399310 0 38373 PETROS A GREGORIOU CHIEF FINANCIAL OFFICER 35.0 0.0 X 287823 0 45995 ANTHONY S GUCCIARDO SVP, STRATEGIC PARTNERSHIPS 35.0 0.0 X 275298 0 13915 DOLORES MACHUCA-RUIZ SENIOR VP, MARKETING 35.0 0.0 X 249667 0 38573 JOSEPH VASSALOTTI CHIEF MEDICAL OFFICER 35.0 0.0 X 232052 0 42901 SHARON PEARCE SVP, GOVT. RELATIONS 35.0 0.0 X 230368 0 38357 JESSICA JOSEPH VP, SCIENTIFIC ACTIVITIES 35.0 0.0 X 224900 0 22422 ELIZABETH TALBOT-MONTGOMERY VP, LEARNING STRATEGIES 35.0 0.0 X 201600 0 18544 RASITHA HERATH VP OF DIGITAL CUSTOMER EXP. 35.0 0.0 X 212365 0 4155 MICHELLE TOY REGIONAL VICE PRESIDENT 35.0 0.0 X 184181 0 29609 BRENITA BROOKS REGIONAL VP - MID-ATLANTIC 35.0 0.0 X 200095 0 12608 SUSAN KETRON THRU 1223 VP, ORGANIZATIONAL 35.0 0.0 X 186500 0 20300 SYLVIA ROSAS MD PRESIDENT 2.0 0.0 X X 0 0 0 Kirk Campbell MD President Elect 2.0 0.0 X X 0 0 0 Paul Palevsky MD Immediate Past President 2.0 0.0 X X 0 0 0 Tracy McKibben Board Chair 2.0 0.0 X X 0 0 0 Anne Barr Chair Elect 2.0 0.0 X X 0 0 0 Anthony Tuggle Immediate Past Board Chair 2.0 0.0 X X 0 0 0 SAMUEL MARCHIO SECRETARY 2.0 0.0 X X 0 0 0 MANISH AGARWAL BOARD MEMBER 1.0 0.0 X 0 0 0 HUBERT ALLEN BOARD MEMBER 1.0 0.0 X 0 0 0 JAIME HERRERA BEUTLER BOARD MEMBER (AS OF 10/23) 1.0 0.0 X 0 0 0 DAVID COOK MD BOARD MEMBER 1.0 0.0 X 0 0 0 MATTHEW COOPER MD BOARD MEMBER (THRU 9/23) 1.0 0.0 X 0 0 0 MONICA DAVY BOARD MEMBER (AS OF 10/23) 1.0 0.0 X 0 0 0 VALERIE DIXON BOARD MEMBER (AS OF 10/23) 1.0 0.0 X 0 0 0 JOHN T GERZEMA BOARD MEMBER 1.0 0.0 X 0 0 0 RENEE GOSLINE BOARD MEMBER 1.0 0.0 X 0 0 0 ORLANDO HAMPTON BOARD MEMBER (THRU 9/23) 1.0 0.0 X 0 0 0 DARRIUS JONES BOARD MEMBER (AS OF 10/23) 1.0 0.0 X 0 0 0 HOLLY MATTIX-KRAMER MD BOARD MEMBER 1.0 0.0 X 0 0 0 ANNE MOTSENBOCKER BOARD MEMBER 1.0 0.0 X 0 0 0 LYNN PINA BOARD MEMBER 1.0 0.0 X 0 0 0 ALISON STEIBER PHD RDN BOARD MEMBER 1.0 0.0 X 0 0 0 MICHAEL J STEVENSON CPA BOARD MEMBER (THRU 9/23) 1.0 0.0 X 0 0 0 SUMESKA THAVARAJAH MD BOARD MEMBER 1.0 0.0 X 0 0 0 BRADLEY A WARADY MD BOARD MEMBER 1.0 0.0 X 0 0 0 JOHN WIGNESWARAN MD BOARD MEMBER 1.0 0.0 X 0 0 0 3368952 0 363597 90 false true false THE AXIS AGENCY 1146 N CENTRAL AVENUE GLENDALE CA 91202 MARKETING/PROMOTION 357597 SLALOM LLC PO BOX 101416 PASADENA CA 91189 DATA STRATEGY CONSUL 243226 REINGOLD INC 1321 DUKE STREET ALEXANDRIA VA 22314 ADVERTISING 179959 CORNERSTONE GOVERNMENT 800 MAINE AVENUE SW 7TH FLOOR WASHINGTON DC 20024 ADVOCACY CONSULTING 168000 ALLEGIANCE FUNDRAISING LLC PO BOX 1932 FARGO NC 58106 DONOR STEWARDSHIP 158246 12 X 384733 8555431 11472987 1390203 20413151 PROGRAM SERVICE SUPPORT 611600 18935394 18935394 GRANT AND CONTRACT REVENUE 611600 1449725 1449725 PROFESSIONAL MEMBERSHIP DUES 511120 576470 576470 20961589 808701 808701 0 2224595 2224595 0 0 0 0 3135460 1334612 3001971 174969 133489 1159643 1293132 1293132 1194415 8555431 1194415 0 0 0 0 0 0 31370 27362 4008 4008 THRIFT STORE REVENUE 448000 606733 606733 S CORPORATION INCOME (SCHEDULE K-1) 532000 77912 77912 MISCELLANEOUS REVENUE 611710 296032 296032 980677 46685853 20965597 77912 5229193 X 674329 674329 434601 434601 0 0 2461913 1989979 241997 229937 0 19999545 17332946 2169305 497294 491824 396192 76742 18890 2377139 2247560 109097 20482 1723182 1399838 249654 73690 0 322929 322929 140692 140692 168000 168000 0 0 6112640 5654852 69135 388653 1601481 1520196 47928 33357 3674043 3221418 57874 394751 0 0 2106582 1714453 302762 89367 557407 459887 23940 73580 0 4423792 3220529 39678 1163585 0 0 159118 129260 23053 6805 229246 190489 29924 8833 EQUIPMENT REPAIR/MAINTENANCE 1263111 894492 158719 209900 DUES AND SUBSCRIPTIONS 320937 283001 29222 8714 MISCELLANEOUS 805261 582503 88716 134042 50047772 42837454 3858438 3351880 700 700 20597655 9912516 1740145 2449325 896739 444788 0 0 0 0 972455 1056395 114092 127055 2212233 1579792 4106247 3533420 613137 572827 18303826 22485063 1920000 2000000 0 300000 0 0 12557809 11545294 59928791 52473755 5675778 4502234 0 0 11197946 8082635 0 0 0 0 0 0 0 0 0 0 11848099 10469080 28721823 23053949 X 21429920 18848746 9777048 10571060 31206968 29419806 59928791 52473755 -3361919 1574757 X false true X true false X 21982428 21825883 28004970 22387636 20413151 114614068 0 0 21982428 21825883 28004970 22387636 20413151 114614068 0 114614068 2656590 2467866 2667957 2902139 3033296 13727848 172335 68969 73733 1110220 0 1425257 243799 186023 833435 783818 902765 2949840 132717013 85035026 0.86360 0.87198 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 168000 168000 46527892 46695892 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 151000 152399 214800 168000 686199 250000 250000 250000 250000 1000000 1500000 0 0 4317740 616109 144167 4789682 5080657 -620779 142138 4317740 5078166 136214 133723 5080657 3758154 1443209 123197 5078166 4226286 -239355 228777 3758154 0.00000 0.82970 0.17030 true false 819041 506760 312281 374588 374588 0 2912618 2652072 260546 572827 RIGHT-OF-USE ASSET 8589084 PERPETUAL TRUST 2671125 OTHER ASSETS 208470 SECURITY DEPOSITS 76615 11545294 0 OPERATING LEASE LIABILITIES 10469080 10469080 X 48304878 1574757 16906 1591663 46713215 -27362 -27362 46685853 50092040 16906 27362 44268 50047772 50047772 SCHEDULE D, PART V, LINE 4: THE ORGANIZATION'S PERMANENTLY RESTRICTED ENDOWMENT CONSISTS OF PERMANENTLY RESTRICTED NET ASSETS HELD PRIMARILY FOR RESEARCH AND PATIENT SUPPORT. THE REMAINING PORTION OF THE DONOR-RESTRICTED ENDOWMENT FUND THAT IS NOT CLASSIFIED IN PERMANENTLY RESTRICTED NET ASSETS IS CLASSIFIED AS TEMPORARILY RESTRICTED NET ASSETS UNTIL THOSE AMOUNTS ARE EXPENDED AND RELEASED FROM RESTRICTIONS. SCHEDULE D, PART X, LINE 2: THE FOUNDATION HAS NOT TAKEN AN UNCERTAIN TAX POSITION THAT WOULD REQUIRE PROVISION OF A LIABILITY UNDER ASC 740, INCOME TAXES. UNDER ASC 740, AN ORGANIZATION MUST RECOGNIZE THE FINANCIAL STATEMENT EFFECTS OF A TAX POSITION TAKEN FOR TAX RETURN PURPOSES WHEN IT IS MORE LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY A TAXING AUTHORITY. THE FOUNDATION DOES NOT BELIEVE THERE ARE ANY MATERIAL UNCERTAIN TAX POSITIONS AND, ACCORDINGLY, IT WILL NOT RECOGNIZE THE FINANCIAL STATEMENT EFFECTS FOR UNRECOGNIZED TAX POSITIONS FOR THE YEAR ENDED MARCH 31, 2024. THE FOUNDATION HAS FILED FOR, AND RECEIVED, INCOME TAX EXEMPTIONS IN THE JURISDICTIONS WHERE IT IS REQUIRED TO DO SO. ADDITIONALLY, THE FOUNDATION HAS FILED INTERNAL REVENUE SERVICE (IRS) FORM 990, AS REQUIRED, AND ALL OTHER APPLICABLE RETURNS IN JURISDICTIONS WHEN IT IS REQUIRED. SCHEDULE D, PART XI, LINE 4B: COST OF GOODS SOLD...............$(27,362) SCHEDULE D, PART XII, LINE 2D: COST OF GOODS SOLD................$27,362 GNY WALK 584285 542110 42175 7798 27302 6643 432 NCA AUTHORS 407113 299097 108016 5335 57828 26300 18553 81 8758448 7714224 1044224 27752 262327 673968 80177 9749846 8555431 1194415 40885 347457 706911 99162 1194415 true TUFTS MEDICAL CENTER INC 800 WASHINGTON STREET 817 BOSTON MA 02111 043400617 501(C)(3) 264567 CKD FELLOW CARIDAD CENTER INC 8645 W BLVD BOYNTON BEACH FL 33472 650149423 501(c)(3) 75000 RESEARCH FELLOW VIRGINIA COMMONWEALTH UNIVERSITY 800 E LEIGH ST STE 3100 RICHMOND VA 23284 546001758 501(c)(3) 75000 RESEARCH FELLOW PRATT MEDICAL GROUP 800 WASHINGTON STREET BOSTON MA 02111 042743894 501(c)(3) 37500 CKD FELLOW CONNECTICUT CHILDREN'S FOUNDATION INC 282 WASHINGTON STREET HARTFORD CT 06106 222619869 501(c)(3) 35000 RESEARCH FELLOW JOHNS HOPKINS UNIVERSITY CENTRAL LOCKBOX 100 S CHARLES STREET BALTIMORE MD 21201 520595110 501(c)(3) 35000 RESEARCH FELLOW THE CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501(c)(3) 35000 RESEARCH FELLOW THE GEORGE WASHINGTON UNIVERSITY 726 ROSS HALL WASHINGTON DC 20037 530196584 501(c)(3) 25000 RESEARCH FELLOW NYU SCHOOL OF MEDICINE PO BOX 415026 BOSTON MA 02241 135562309 501(c)(3) 24000 CKD FELLOW JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE 3910 KESWICK RD N BLD BALTIMORE MD 21211 520595110 501(c)(3) 19575 RESEARCH FELLOW ALBERT EINSTEIN COLLEGE OF MEDICINE 1300 MORRIS PARK AVENUE BRONX NY 10461 830621846 501(c)(3) 14840 RESEARCH FELLOW Wake Forest University Health Sciences PO Box 604110 Charlotte NC 282604110 223849199 501(c)(3) 9250 RESEARCH FELLOW 12 0 PATIENT ASSISTANCE 543 432441 CKD FELLOW 1 2160 SCHEDULE I, PART I, LINE 2: The organization awards significant grants to advance kidney disease research, including Clinical Scientist Grants, Young Investigator Grants, Health Equity Community Engagement Awards, and Professional Council Grants. A dedicated Research Award Committee annually reviews applications and selects recipients. The organization ensures strict oversight of grant funds, with continued funding dependent on an approved annual progress review and fund availability. Additionally, the organization offers grants, scholarships, and patient assistance programs to support individuals living with kidney disease. X X X X X false true false false false false false true false KEVIN LONGINO CHIEF EXECUTIVE OFFICE 422493 0 62300 0 0 0 16900 0 20945 0 522638 0 0 0 KERRY K WILLIS CHIEF SCIENTIFIC OFFICER 380310 0 19000 0 0 0 17428 0 20945 0 437683 0 0 0 PETROS A GREGORIOU CHIEF FINANCIAL OFFICER 270223 0 17600 0 0 0 16213 0 29782 0 333818 0 0 0 ANTHONY S GUCCIARDO SVP, STRATEGIC PARTNERSHIPS 259698 0 15600 0 0 0 12985 0 930 0 289213 0 0 0 DOLORES MACHUCA-RUIZ SENIOR VP, MARKETING 234767 0 14900 0 0 0 8831 0 29742 0 288240 0 0 0 JOSEPH VASSALOTTI CHIEF MEDICAL OFFICER 219752 0 12300 0 0 0 13185 0 29716 0 274953 0 0 0 SHARON PEARCE SVP, GOVT. RELATIONS 219068 0 11300 0 0 0 8763 0 29594 0 268725 0 0 0 JESSICA JOSEPH VP, SCIENTIFIC ACTIVITIES 212500 0 12400 0 0 0 12750 0 9672 0 247322 0 0 0 ELIZABETH TALBOT-MONTGOMERY VP, LEARNING STRATEGIES 193000 0 8600 0 0 0 7720 0 10824 0 220144 0 0 0 RASITHA HERATH VP OF DIGITAL CUSTOMER EXP. 203365 0 9000 0 0 0 3503 0 652 0 216520 0 0 0 MICHELLE TOY REGIONAL VICE PRESIDENT 177881 0 6300 0 0 0 0 0 29609 0 213790 0 0 0 BRENITA BROOKS REGIONAL VP - MID-ATLANTIC 189295 0 10800 0 0 0 1893 0 10715 0 212703 0 0 0 SUSAN KETRON THRU 1223 VP, ORGANIZATIONAL 178400 0 8100 0 0 0 6845 0 13455 0 206800 0 0 0 SCHEDULE J, PART I, LINE 4B: THE ORGANIZATION HAS A SECTION 457(F) SENIOR STAFF FLEXIBLE BENEFIT PLAN THAT PROVIDES SENIOR MANAGEMENT EMPLOYEES WITH A BENEFIT ALLOWANCE CONTRIBUTED BY THE ORGANIZATION, WHICH CAN BE USED FOR VARIOUS BENEFIT OPTIONS, INCLUDING A CAPITAL ACCUMULATION ACCOUNT. THERE WERE NO ACCRUED BENEFITS TO THE 457(F) PLAN DURING CALENDAR YEAR 2023. SCHEDULE J, PART I, LINE 7: SCHEDULE J, PART II, COLUMN (B)(II) REPORTS DISCRETIONARY INCENTIVE AMOUNTS THAT WERE APPROVED BY THE COMPENSATION COMMITTEE BASED UPON INDIVIDUAL AND ORGANIZATIONAL PERFORMANCE. X 1349 1334612 SALES PROCEEDS X 9 55591 MARKET QUOTATION 8 false true true SCHEDULE M, PART I, COLUMN (B), LINE 9: THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS. SCHEDULE M, PART I, LINE 32B: THE ORGANIZATION CONTRACTS WITH CHARITABLE ADULT RIDES AND SERVICES FOR ADMINISTERING THE FOUNDATION'S VEHICLE DONATION PROGRAM. THE ORGANIZATION IS REPORTING THE NUMBER OF ITEMS CONTRIBUTED FOR CARS AND VEHICLES. FORM 990, PART III, LINE 4A: PROFESSIONAL EDUCATION - The organization provides accredited medical education programs, quality improvement initiatives, and clinical tools and resources for the interprofessional healthcare team. Educational opportunities include national meetings covering a broad range of topics and specialized local or regional seminars. The NKF Spring Clinical Meetings are NKF's premier interprofessional continuing education (CE) activity, recognized as the leading learning experience for the nephrology community. Drawing over 3,400 attendees annually, the event features more than 500 research posters and 140 educational sessions, fostering collaboration and advancing kidney care. Since 1981, the organization has published peer-reviewed medical journals delivering timely insights and cutting-edge research on kidney disease to the global nephrology community. Four of these esteemed journals are available on ScienceDirect, a leading platform for professional-level scientific and medical information, serving over 11 million users worldwide. The organization's Kidney Learning Solutions (KLS) offers comprehensive education and quality improvement activities in various formats, including print and digital resources. These programs are designed to support the management and treatment of chronic kidney disease (CKD) and its associated comorbidities. The foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) develops and publishes evidence-based clinical practice guidelines and commentaries, regularly updated to reflect the latest advancements in kidney patient care. Beyond guideline development, KDOQI contributes to broader policies and educational resources to facilitate the implementation of these recommendations. All KDOQI guidelines and commentaries are published in the American Journal of Kidney Diseases (AJKD), NKF's flagship journal. FORM 990, PART III, LINE 4B: COMMUNITY SERVICES AND ASSISTANCE TO AFFILIATES (DEFINED BELOW) - THE ORGANIZATION'S SCREENING PROGRAMS TARGET INDIVIDUALS MOST AT RISK OF POTENTIAL MEDICAL CONDITIONS THAT MAY LEAD TO FUTURE KIDNEY DISEASE. THE NATIONAL KIDNEY FOUNDATION CONDUCTS A SERIES OF PROGRAMS DESIGNED TO RAISE AWARENESS AMONG THE GENERAL PUBLIC ABOUT KIDNEYS, RISK FACTORS FOR KIDNEY DISEASE, AND HOW TO PROTECT THE KIDNEYS. ASSISTANCE IS PROVIDED BY THE ORGANIZATION TO ITS AFFILIATES (DEFINED BELOW). THE ORGANIZATION PROVIDES CONSULTATION, GUIDANCE, TRAINING AND ADVOCACY. SPECIFIC GUIDANCE IS PROVIDED THROUGH EDUCATIONAL PROGRAMS FOR HEALTH CARE PRACTITIONERS AND KIDNEY DISEASE PATIENTS. AFFILIATES ARE KEPT UP TO DATE WITH CURRENT PUBLICATIONS FROM THE ORGANIZATION, BOTH CLINICAL AND NON-CLINICAL. "AFFILIATES" - NATIONAL KIDNEY FOUNDATION ("NKF") HAS A CHARTERED NETWORK OF 9 AFFILIATED ORGANIZATIONS ACROSS THE COUNTRY. THE AFFILIATES ARE SEPARATE LEGAL ENTITIES WHICH IN TANDEM WITH THE FOUNDATION HELP IMPLEMENT THE ORGANIZATIONAL MISSION AND PRIOIRITIES. NKF AND ITS AFFILIATES HAVE AGREEMENTS UNDER WHICH A PORTION OF THE REVENUE RECEIVED BY AFFILIATES IS SHARED WITH NKF FOR THE EXPRESS PURPOSE OF FULFILLING ITS MISSION. FORM 990, PART III, LINE 4C: Patient services - NKF offers a wide range of patient services designed to support, educate, and empower individuals living with kidney disease. Programs include advocacy training, transportation assistance, support groups, and workshops tailored to the needs of kidney patients. Through the NKF Cares Helpline, over 20,000 individuals received personalized guidance and support, while the NKF Peers Program connected new patients with experienced volunteers to provide mentorship and encouragement. Additionally, tens of thousands of educational brochures were distributed, offering condition-specific information to help patients navigate their kidney health journey. FORM 990, PART III, LINE 4D: 1) Public & Population health - The organization's website, www.kidney.org, serves as a vital resource for kidney disease education, attracting millions of visitors annually. Patients rely on the Kidney Topics pages for comprehensive information on various kidney conditions, including nutrition and treatment options. The organization remains committed to educating and supporting high-risk groups by providing tailored information and interventions, particularly in underserved communities. CKDIntercept is the Foundation's groundbreaking initiatives focused on improving chronic kidney disease testing, recognition, and management in primary care. EXPENSES: $5,309,314. GRANTS: $0. REVENUE: $1,349,470. 2) Research - The organization annually awards 5-6 Young Investigator Grants and 2 Health Equity Community Engagement Awards. Young Investigator Grants fund patient-oriented clinical research studies that address critical issues affecting individuals with kidney disease. Health Equity Community Engagement Awards support community-focused projects aimed at preventing, reducing, or eliminating kidney health disparities, fostering measurable impact at the local level. EXPENSES: $4,428,116. GRANTS: $676,489. REVENUE: $179,569. FORM 990, PART VI, SECTION B, LINE 11B: THE ORGANIZATION'S BOARD OF DIRECTORS ASSIGNS THE FINANCE COMMITTEE THE OVERSIGHT RESPONSIBILITY OF THE IRS FORM 990 AND ITS SUPPLEMENTAL SCHEDULES. FORM 990 IS REVIEWED BY THE CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER, AND FINANCE COMMITTEE PRIOR TO FILING. THE FINAL AND SIGNED FORM 990 IS MADE AVAILABLE TO THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C: TO IDENTIFY CONFLICTS OF INTEREST, OFFICERS, DIRECTORS (GOVERNING BOARD MEMBERS) AND SENIOR STAFF MUST ANNUALLY DISCLOSE ANY POTENTIAL CONFLICTS OF INTEREST. THE ORGANIZATION'S AUDIT COMMITTEE AND THE COMPLIANCE OFFICER MANAGES THE DISCLOSURE AND MONITORING PROCESSES RELATED TO POTENTIAL CONFLICTS OF INTEREST. EACH PERSON ALSO HAS THE RESPONSIBILITY TO REPORT HIS OR HER OWN CONFLICTS OF INTEREST, WHETHER ACTUAL OR PERCEIVED, WHEN SUCH CONFLICTS ARISE DURING A MEETING. AFTER DISCLOSURE OF THE MATERIAL FACTS, THE INDIVIDUAL SHALL LEAVE THE BOARD OR COMMITTEE MEETING WHILE THE POTENTIAL CONFLICT OF INTEREST IS DISCUSSED AND DETERMINED. THE DISCLOSURE, DECISIONS MADE, AND ACTIONS TAKEN ARE DOCUMENTED IN THE MINUTES OF THE MEETING. FORM 990, PART VI, SECTION B, LINES 15A AND 15B: THE COMPENSATION COMMITTE (COMPRISED OF INDEPENDENT BOARD MEMBERS) IS RESPONSIBLE FOR ESTABLISHING GUIDELINES AND APPROVING COMPENSATION FOR SENIOR MANAGEMENT POSITIONS (CEO, OTHER OFFICERS AND KEY EMPLOYEES) ON AN ANNUAL BASIS. THE COMPENSATION COMMITTEE USES AN INDEPENDENT CONSULTANT AND/OR COMPENSATION BENCHMARK STUDIES TO DETERMINE COMPENSATION FOR SENIOR MANAGEMENT. FORM 990, PART VI, SECTION C, LINE 19: THE ORGANIZATION MAKES CERTAIN GOVERNING DOCUMENTS AVAILABLE TO THE PUBLIC THROUGH ITS WEBSITE, WWW.KIDNEY.ORG. SUCH DOCUMENTS INCLUDE THE AUDITED FINANCIAL STATEMENTS, ANNUAL REPORTS, CONFLICT OF INTEREST POLICY, IRS DETERMINATION LETTER AND THE MOST RECENT FORM 990. OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST TO THE COMPLIANCE OFFICER. FORM 990, PART VIII, LINE 10: THE REPORTING ORGANIZATION'S INVENTORY IS PRIMARILY MADE UP FROM EDUCATIONAL MATERIALS SUCH AS PROFESSIONAL EDUCATION BROCHURES FOR THE RENAL PROFESSIONALS AS WELL AS PATIENT EDUCATION BROCHURES FOR THE PATIENTS. FORM 990 PART IX LINE 11G DESCRIPTION:CONSULTING TOTAL FEES:2648633 FORM 990 PART IX LINE 11G DESCRIPTION:HONORARIA TOTAL FEES:922004 FORM 990 PART IX LINE 11G DESCRIPTION:AUDIO VISUAL TOTAL FEES:650267 FORM 990 PART IX LINE 11G DESCRIPTION:JOURNAL PROFESSIONAL FEES TOTAL FEES:475425 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER PROFESSIONAL FEES TOTAL FEES:1416311